Medincell【MEDCL】銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

17.42

買値

17.28

売値

17.42

出来高

54,459

16.94 日の範囲 17.42

5.92 52 週間の範囲 19.00

時価総額

506.415M

前日終値

17.16

始値

17.16

時刻

250

17.42

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

66,573

発行済株式数

29,070,871

配当利回り

PER

-20.23

1 株当たり利益 (EPS)

-0.86

歳入

12.29M

純利益

-25.04M

セクター

Pharmaceutical Preparations

業界

Pharmaceutical Preparations

ウェブサイト

www.medincell.com

本社

Jacou, Occitan, Fra

設立

Medincell SA is listed in the Pharmaceutical Preparations sector of the ユーロネクスト with ticker MEDCL. The last closing price for Medincell was 17.16 €. Over the last year, Medincell shares have traded in a share price range of 5.92 € to 19.00 €.

Medincell currently has 29,070,871 shares in issue. The market capitalisation of Medincell is 498.86 € million. Medincell has a price to earnings ratio (PE ratio) of -20.23.

MedinCell : Information relative au nombre d’actions composant le capital social et au nombre total des droits de vote

Article 223-16 du règlement Général de l’Autorité des Marchés Financiers Regulatory News: MedinCell (Paris:MEDCL) : Place de cotation : Euronext Paris, Compartiment B Code ISIN : FR0004065605...

Medincell: 25% Raise in 2024 UZEDY® Revenue Outlook & Key Milestone Reached for Olanzapine LAI Clinical Phase 3

ACCESS HERE THE COMPLETE PRESS RELEASE Medincell’s (Paris:MEDCL) partner Teva Pharmaceuticals shared today as part of its Q3 2024 results, the following information: About UZEDY® Updated 2024...

Medincell: 25% Raise in 2024 UZEDY® Revenue Outlook & Key Milestone Reached for Olanzapine LAI clinical Phase 3

Regulatory News: Medincell’s (Paris:MEDCL) partner Teva Pharmaceuticals shared today as part of its Q3 2024 results, the following information: About UZEDY® Updated 2024 Revenue Outlook:...

Medincell’s Partner Teva Unveils New Phase 3 Positive Results for Olanzapine LAI, and Presents Real-World Data on UZEDY® at Psych Congress 20241

Medincell (Paris:MEDCL): ACCESS HERE THE COMPLETE PRESS RELEASE TEV-‘749 / mdc-TJK - Investigational Olanzapine Long-Acting Injectable Teva presented positive data from the initial period of...

Teva, partenaire de Medincell, dévoile de nouveaux résultats positifs de phase 3 pour l'olanzapine LAI et présente des données en situation réelle sur UZEDY® à Psych Congress 20241

Regulatory News: Medincell (Paris:MEDCL) : TEV-‘749 / mdc-TJK - Traitement injectable à action prolongée expérimental d’olanzapine Teva a présenté de nouvelles données positives portant sur la...

MedinCell : Information relative au nombre d’actions composant le capital social et au nombre total des droits de vote

Medincell annonce sa participation à plusieurs conférences investisseurs de premier plan

Regulatory News: Le management de Medincell (Paris:MEDCL) participera aux conférences investisseurs suivantes en novembre et décembre 2024. Truist Securities BioPharma Symposium Date : 7...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.18	-1.02272727273	17.6	17.68	16.5	77866	17.03113646	DE
4	2.5	16.7560321716	14.92	18.46	14.54	78127	16.86542657	DE
12	-1.16	-6.24327233584	18.58	19	14.54	66573	16.55878681	DE
26	3.32	23.5460992908	14.1	19	12.68	71557	15.92332466	DE
52	11.22	180.967741935	6.2	19	5.92	75209	13.19108811	DE
156	7.26	71.4566929134	10.16	19	4.73	49707	10.1806715	DE
260	10.8	163.141993958	6.62	20	4.35	46898	10.43190285	DE

銘柄コード	株価	出来高
MLAAHAmatheon Agri Holding NV	0.02 € (100.00%)	5k
GNROGeNeuro SA	0.0768 € (25.49%)	200
BIDSGascogne DS	0.005 € (25.00%)	150.51k
ALSAFSAFE	0.11 € (23.73%)	39.98k
ALKKOKKO International SA	0.112 € (21.21%)	4.13M
ALIMOGroupimo	0.189 € (-40.94%)	392
MLUMGUmalis Group	1.30 € (-31.22%)	1.71k
MLNMAMiguet Et Associes	0.075 € (-24.62%)	1.72k
MLSEQSequa Petroleum NV	0.008 € (-20.00%)	23k
VACBSPierre & Vacances	0.05 € (-15.25%)	35.99k
BCPBanco Comercial Portugues SA	0.4446 € (-0.49%)	69.24M
ALNEVNeovacs	0.0002 € (0.00%)	41.4M
ALCYBCybergun	0.0001 € (0.00%)	30.32M
INGAING Groep NV	14.652 € (-1.16%)	14.06M
ACACredit Agricole SA	13.05 € (-1.66%)	8.06M

銘柄コード

株価

出来高